WW International, Inc.'s SEC filings document the regulatory record for Weight Watchers' subscription-based weight-management and clinical businesses. Recent Forms 8-K furnish quarterly results, shareholder letters, Regulation FD disclosures about term-loan prepayment actions, and material governance events involving directors, board committees and interim executive officers.
The company's proxy materials cover annual-meeting voting matters, director elections, board independence, committee service and non-employee director compensation. Its filings also identify WW common stock, no par value, registered on the Nasdaq Stock Market and provide formal disclosure of capital-structure, compensation and corporate-governance matters.
WW INTERNATIONAL, INC. executive Jonathan Volkmann filed an initial ownership report showing equity-based holdings in the company. He holds Restricted Stock Units tied to 16,000 shares of common stock and Performance Stock Units tied to 7,200 shares, plus 552 shares of common stock.
The awards were granted on December 18, 2025 and will vest in stages on January 1, 2027, January 1, 2028 and January 1, 2029. The PSUs also depend on stock price performance measured using volume weighted average closing prices over specified 20‑day periods through January 1, 2029.
WW International, Inc. filed an amended report to detail new board committee assignments and its interim leadership approach. Following their recent election to the Board, Lisa Gavales was appointed to the Compensation and Benefits Committee and the Strategy and Finance Committee, while Sue E. Gove joined the Audit Committee and the Nominating and Corporate Governance Committee, effective April 8, 2026.
The Board also confirmed it will continue operating under the existing Office of the CEO structure, led by CFO Felicia DellaFortuna and COO Jon Volkmann, and will not appoint an interim CEO. The Board states this arrangement provides experienced leadership and continuity while a permanent CEO search proceeds with the help of an executive search firm.
WW International, Inc., known as Weight Watchers, appointed Lisa Gavales and Sue E. Gove as independent directors effective April 7, 2026. They will serve until the 2026 annual meeting and are expected to stand for election.
The Board increased to six directors, all classified as independent under Nasdaq listing standards. Each new director will receive an annual cash retainer of $90,000, plus $12,500 per year for each standing Board committee membership, with 2026 amounts prorated. Subject to their election at the 2026 annual meeting, they will be eligible for an annual restricted stock unit grant targeting $135,000 in value.
The company highlights their deep consumer, digital, turnaround and financial leadership experience to support Weight Watchers’ strategic transformation and growth focus in science-backed weight management and digital health.
WW International (Weight Watchers) announced major leadership and board changes. CEO Tara Comonte resigned effective March 31, 2026, and the company created an Interim Office of the CEO led by CFO Felicia DellaFortuna and COO Jonathan Volkmann while the board conducts a search for a new CEO.
Chief Legal and Administrative Officer and Secretary Jacqueline Cooke will depart April 10, 2026, and will receive a cash separation payment, extended health benefits and legal fee reimbursement under a Separation Agreement. Senior vice president Debra Cotter will become chief legal officer and secretary.
Directors Julie Bornstein and Fallon O’Connor also resigned, and the board reduced its size from seven to four members and amended its bylaws to allow as few as three directors. The company reaffirmed its first quarter 2026 subscriber estimates and full-year 2026 financial guidance.
The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting 0 shares of common stock of WW International Inc. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The filing shows amount beneficially owned: 0 and percent of class: 0%. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
WW International, Inc. Schedule 13G shows that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report shared beneficial ownership of 591,173 shares of common stock, representing 5.9% of the class as reported on the cover pages.
The filing is a joint filing executed and signed on 03/18/2026 and includes a Joint Filing Agreement among the three filers.
WW International, Inc. reports its annual results and outlines a major post‑bankruptcy reset. The company emerged from Chapter 11 on June 24, 2025, discharging approximately $1,116.0 million of prepetition credit facilities and $500.0 million of senior secured notes. It put in place a new $465.0 million senior secured term loan maturing in 2030 and applied fresh start accounting, creating separate Successor and Predecessor periods.
WW now operates as a single reportable segment built around two main lines: a “Behavioral” subscription business and a U.S. “Clinical” Med+ telehealth offering centered on GLP‑1 and related weight‑management medications. As of the end of fiscal 2025, it had about 2.6 million Behavioral subscribers and 130.2 thousand Clinical subscribers
WW International reported mixed fourth quarter and full-year 2025 results as it transitions from a traditional behavioral weight-loss model to an integrated clinical and GLP-1 focused platform. Q4 2025 total revenue was $163 million, down 12% year-over-year, with behavioral subscription revenue falling 17% while clinical subscription revenue grew 32% to $27 million. The company posted a Q4 net loss of $6 million, a net loss margin of 3.6%, and Adjusted EBITDA of $18 million with an 11.1% margin, down from $46 million and a 25.1% margin a year earlier.
Management highlighted strong momentum in its clinical Med+ offering and GLP-1 Success Program, noting end-of-period clinical subscribers rose 42% to 130,000 within a total subscriber base of 2.8 million. For 2026, WW guided to revenue of $620–$635 million and Adjusted EBITDA of $105–$115 million, and estimated first quarter 2026 end-of-period subscribers of about 2.65 million, including roughly 200,000 clinical subscribers. Following its June 2025 Chapter 11 reorganization, WW ended 2025 with $160 million of cash and a significantly reduced term loan of $465 million, cutting total debt by more than 70% from $1.6 billion and improving net debt to about $305 million.
Cooper Creek Partners Management LLC has disclosed a significant stake in WW International, Inc. As of December 31, 2025, the firm reports beneficial ownership of 649,985 shares of WW International common stock, representing 6.5% of the outstanding class.
Cooper Creek reports sole voting and sole dispositive power over all 649,985 shares, with no shared power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of WW International, indicating a passive investment stance.
WW International director Julie Bornstein reported acquiring 1,166 shares of WW International, Inc. common stock on 01/02/2026. The transaction was coded "A" and priced at $0.00 per share, indicating an award rather than an open‑market purchase. Following this grant, she beneficially owns 2,918 shares of common stock in direct ownership. According to the accompanying note, these shares are subject to transfer restrictions, meaning they cannot be freely sold or transferred until specified conditions are met.